National
Vaccine Program Office
Inter-Agency Vaccine Group Research Program
Awards for Fiscal Year 2003 |
Principal Investigator(s)
(click link for PI info.) |
Institution |
Proposal Number
(Abstract Link) |
Proposal Title |
Awasthi, Shally |
U.S. Agency for International Development |
N55 |
Association of Intestinal Intussusception
and Diarrhoea: Six-Country Surveillance |
Ball,
Robert |
Food and Drug Administration |
C23 |
Arthritis after Lyme Vaccine:
Case Control Study |
Beall,
Bernard |
Centers for Disease Control and Prevention
|
C3 |
Molecular Surveillance Within
Year 2002 and 2003 Invasive Pneumococcal Isolates for Capsular Switching
Events from 7 Valent Conjugate Vaccine Serotypes to Those not Covered
by This Vaccine |
Bell, Beth P. |
Centers for Disease Control and Prevention
|
N36 |
Estimating Hepatitis A Vaccine
Coverage Among Children Living in States Where Routine Vaccination
is Recommended |
Bernier,
Roger |
Inter-Agency Vaccine Group |
C19 |
Improving Public Participation
in Dialogue and Deliberation About Vaccines |
Breese, Joseph;
Tu, Van Phan.;
Nguon, Huynh Vinh Hai |
Centers for Disease Control and Prevention
|
C5 |
Determination of the Epidemiology
of and Risk Factors of and Validation of Clinical Case Definitions
for Intussusception Among Infants in Ho Chi Minh City, Vietnam |
Breiman, Robert;
Fukuda, Keiji |
Centers for Disease Control and Prevention
|
N30 |
Influenza Surveillance and Estimate
of the Burden of Influenza in Bangladesh |
Breiman, Robert;
Zaman, K. |
U.S. Agency for International Development |
N56 |
Defining Incidence of IS in Bangladesh
in Preparation for a Phase III trial of a New Rotavirus Vaccine
|
Brennan,
Michael J. |
Food and Drug Administration |
N70 |
Development of Novel Recombinant
Vaccine to Treat Adult Pulmonary Tuberculosis |
Cannon, Michael; Inoue,
Naoki; Schmid, Scott |
Centers for Disease Control and Prevention
|
N26 |
Congential Cytomegalovirus (CMV)
Epidemiology and Diagnostics Development |
Cardo, Denise;
Jernigan, John |
Centers for Disease Control and Prevention
|
C11 |
Assessing the Impact of Influenza
Vaccination Programs in Acute and Long-term Healthcare Facilities
|
Cetron, Martin S. |
Centers for Disease Control and Prevention
|
N17 |
Yellow Fever Vaccine-Associated
Adverse Event Surveillance and Risk Assessment |
Chumakov, Konstantin
|
Food and Drug Administration |
N67 |
Advanced Immunological Techniques
for Analysis of Polivirus Vaccines and Vaccine-Derived Polioviruses
|
Chumakov, Konstantin
|
Food and Drug Administration |
C22 |
Rapid Microarray Screening of
Vaccine-Derived Polioviruses |
Curtis, Christine |
Centers for Disease Control and Prevention
|
C15 |
Source of Bordetella Pertussis
Among Infants with Whooping Cough |
Dowdle, Walter |
National Vaccine Program Office; Centers for
Disease Control and Prevention |
C18 |
U.S. Polio Laboratory Containment
Survey |
Epstein,
Suzanne |
Food and Drug Administration |
N65 |
Influenza Pandemic Preparedness:
Vaccination with Conserved Influenza Virus A Components by DNA Prime-Viral
Boost Regimens |
Fast, Patricia |
National Vaccine Advisory Committee |
N41 |
Workshop: Pneumococcal Disease
Prevention in Adults -- Potential Vaccine Strategies |
Feikin, Daniel |
Centers for Disease Control and Prevention
|
C10 |
Enhancing Response to Haemophilus
Influenzae Type b Conjugate Vaccine Among Kenyan Infants Through
Intermittent Malaria Prophylaxis |
Feinstone, Stephen |
Food and Drug Administration |
C20 |
A Chimeric Mouse Model for the
Progagation of Hepatitis C Virus |
Fisbein, Daniel |
Centers for Disease Control and Prevention
|
C16 |
Effectiveness of an Assessment/Reminder
and Cost Subsidy on Vaccination of Adolescents and Adults in Non-Traditional
Settings |
Gust, Deborah |
Centers for Disease Control and Prevention
|
C14 |
NVPO 2002 - Understanding Parental
Uncertainty Regarding Childhood Immunization: An NIS Module of Parental
Knowledge, Attitudes and Beliefs NVPO Continuation Project 2002 - Educational Material Design
and Testing for Audience Segments of Parents Based Upon Health and
Immunization Attitudes and Beliefs |
Hennessy, Thomas |
Centers for Disease Control and Prevention
|
C13 |
Impact of Pneumococcal Conjugate
Vaccine on Carriage of Streptococcus Pneumoniae in Rural Alaska
Native Communities |
Hughes, Hayley |
Centers for Disease Control and Prevention
|
N45 |
Evaluating the Feasibility of
a Pediatric Hospital-Based Sentinel Surveillance Network for Vaccine
Preventable Diseases |
Hutin, Yvan |
U.S. Agency for International Development |
N54 |
A Standardized Procedure to Assess
Technologies Relevant to Immunization Programmes for Potential Inclusion
into a WHO Model List of Essential Equipment |
Iwane, Marika K. |
Centers for Disease Control and Prevention
|
N46 |
Identifying Risk Factors for
Severity of Influenza and RSV Illness: Comparative Study of Inpatients,
Outpatients, and Well Children |
Jumann,
Aisha O. |
Centers for Disease Control and Prevention
|
N50 |
Surveillance for Varicella and
Herpes Zoster in VSD Populations |
Karem, Kevin L.; Unger,
Elizabeth R. |
Centers for Disease Control and Prevention
|
N20 |
Validation of Noninvasive Method
for Monitoring Immune Response to Human Papillomavirus |
Katz, J.;
Sambhara, S. |
Centers for Disease Control and Prevention
|
N27 |
Use of Novel Immunodulators and
Delivery Strategies to Enhance Immunogenicity and Efficacy of Pandemic
Vaccines in Mice |
Kohl,
Katrin |
Centers for Disease Control and Prevention
|
N52 |
Comprehensive Evaluation of Applicability,
Reliability, Sensitivity, and Specificity of Newly Developed Standardized
Case Definitions for Adverse Events Following Immunization |
Krause, Philip |
Food and Drug Administration |
N60 |
Development of Nanobiosensor
for Detecting Adventitious Viral Agents in Vaccines |
Levis, Robin; Weir,
Jerry |
Food and Drug Administration |
N66 |
Development of Improved Assays
for Evaluating Vaccines Against West Nile Virus and Other Emerging
Viral Pathogens |
Lewis, Andrew |
Food and Drug Administration |
C21 |
Evaluation of VERO Cell Evolution
from a Nontumorigenic to a Tumorigenic Phenotype |
Lewis, Andrew;
Peden, Keith |
Food and Drug Administration |
N59 |
Follow-up Studies on the Detection
of SV40 in Environmental Samples: Is SV40 a Human Infectious Agent?
|
Longini, Ira |
National Institutes of Health |
C2 |
Statistical and Mathematical
Modeling of the Use of Limited Supplies of Antiviral Agents for
Pandemic Influenza |
Loparev, Vladimir;
Schmid, Scott |
Centers for Disease Control and Prevention
|
N25 |
Evaluation of Potentially Virulent
Mutations in Oka Vaccine Substrains Associated with Adverse Events
and in Wild-Type Strains Associated with High Rates of Vaccine Breakthrough
Infection |
Meysick,
Karen |
Food and Drug Administration |
N69 |
Identification of Potential Vaccine
Antigen Candidates Associated with a Novel Yersinia Pestis Chromosomal
Type III Secretion System |
Murphy,
Trudy V. |
Centers for Disease Control and Prevention
|
N80 |
An Assessment of Neonatal Vaccination
with Current and Future Vaccines |
Rosenstein, Nancy |
Centers for Disease Control and Prevention
|
N31 |
Evaluation of the Serogroup W135
Meningococcal Polysaccharide Vaccine as a Control Measure for Meningococcal
Epidemics in an African "Meningitis Belt" Country |
Rubin, Fran A. |
National Institutes of Health |
N12 |
Workshop to Discuss Prevention
of Group A Streptococcal Diseases and Their Sequelae with a Focus
on Vaccine Related Issues |
Rubin,
Steven |
Food and Drug Administration |
N57 |
Valdiation of the Newborn Rat
Neurovirulence Assay for Mumps Virus Vaccines |
Rupprect, C.E. |
Centers for Disease Control and Prevention
|
C4 |
Utility of Intradermal Multi-Site
Vaccine Application in Rabies Prophylaxis |
Sampson,
Jacquelyn |
Centers for Disease Control and Prevention
|
N19 |
Development of a Novel Streptococcus
Pneumoniae Microarray for Detection of Pneumococci, Antibotic Sensitivity,
and Diagnosis of Pneumococcal Disease |
Schleiss, Mark R. |
National Institutes of Health |
N10 |
Epidemiology of Cytomegalovirus
(CMV) Infection in Children Attending Day Care Centers in Cincinnatti,
Ohio: Application to CMV Vaccine Studies |
Schmaljohn,
Connie |
Department of Defense |
N2 |
Multiagent DNA Vaccines |
Schmid, D. Scott |
Centers for Disease Control and Prevention
|
C7 |
Comparison of Cell-Mediated Immune
Responses to Natural VZV infection and Oka Vaccine Using Fluorescent-Microsphere-Based
Multiplex Cytokine Analysis |
Schrag,
Stephanie |
Centers for Disease Control and Prevention
|
N34 |
Characterizing the Need for Maternal
or Adolescent Group B Sstreptococcal Vaccination in a Developing
Country Setting: Assessment of Disease Burden and Access to Care
at Chri Hani Baragwanath Hospital, Soweto, South Africa |
Schrag,
Stephanie; Schuchat, Anne |
Centers for Disease Control and Prevention
|
C12 |
Group B Streptococcal Vaccine
Development: Characterization of Invasive Disease Strains |
Shay, David K. |
Centers for Disease Control and Prevention
|
N49 |
Evaluation of Neuropsychological
Outcomes Among Children Randomly Exposed to Differing Amounts of
Thimerosal During Infancy: Follow-up of Italian DTaP Trial Participants
|
Singleton, James |
Centers for Disease Control and Prevention
|
C17 |
Rapid Annual Assessment of Influenza
Vaccine Utilization Among Adults |
Stokley, Shannon |
Centers for Disease Control and Prevention
|
N39 |
Provider Response to Vaccine
Shortages and the Ability to Recall Children |
Terebuh, Pauline |
Centers for Disease Control and Prevention
|
C8 |
Transmission of Influenza Viruses
Between Pigs and Humans in Iowa |
Tripp,
Ralph |
Centers for Disease Control and Prevention
|
C6 |
Characterization of the CX3C
Chemokine-Like Region in the G Glycoprotein of Respiratory Syncytial
Virus |
Uyeki, Timothy |
Centers for Disease Control and Prevention
|
C9 |
Effectiveness of Maternal Influenza
Vaccination to Prevent Influenza in Infants |
Whitney, Cynthia |
Centers for Disease Control and Prevention
|
N18 |
Population-Based Surveillance
to Identify the Impact of Introduction of Pneumococcal Conjugate
Vaccine (PCV7) on the Occurrence of Radiographically-Confirmed Pneumonia
in Adults |
Wortley, Pascale |
Centers for Disease Control and Prevention
|
N42 |
Updating Influenza Pandemic Preparedness
and Response Planning: Development of Table Top Exercises for State
and Local Planning |
Zollinger,
Wendell |
Department of Defense |
N19 |
Production and Evaluation of
a Clinical Lot of Meningococcal Native Outer Membrane Vesicle Vaccine
Prepared from a Strain with Genetically Detoxified Lipopolysaccharide
|